~~

! 2 1 7 6 3 6 6 _ MAXPCCAL _ REGIL ME-E VEL YN-G_ 0 1 1 5 1 9 6 9 _ L 2 4 0 2 1 6 0 0 2 0 _ EMEDSAPCC-3 8 0 0 3 5 2 2

- 0148531
- 168011108506034

PATIENT NAME
REGILME, EVELYN G.
MAXICARE PCC - ALABANG

DOB AGE SEX SAMPLE RECEIVE DATE/TIME YOUR REF REFERRING DOCTOR
JAN 15 1969 55Y F FEB 16 2024 07:33 EMEDSAPCC-3800352-2014853 NOT PROVIDED
-1168011108506034

ANALYTE RESULT SI UNIT REF RANGE RESULT CONV UNIT REF RANGE

Renal Function
Sodium 138 mmol/L 136 - 145 138 meq/L 136 - 145
Creatinine (with eGFR) 67.9 umol/L 50.4 - 98.1 0.767 mg/dL 0.570 - 1.109
2
eGFR 91.4* mL/min/1.73m >= 60.0
Estimated glomerular filtration rate (eGFR) is invalid for pregnant women, those with extreme body size, muscle mass and nutritional status.

*The CKD-EPI equation is applicable only for 18 years old and above. All estimating equations used in adult populations become less accurate
as GFR increases, such as in people with normal kidney function. Please correlate clinically.

Potassium 4.5 mmol/L 3.5 - 5.1 4.5 meq/L 3.5 - 5.1

Urea / BUN 4.6 mmol/L 2.5 - 6.7 13 mg/dL 7 - 19
Uric Acid 248 umol/L 150 - 350 4.24 mg/dL 2.57 - 5.99

Liver Function
ALT (SGPT) 18 IU/L < 55 18 U/L < 55

Lipid Studies
Total Cholesterol 4.65 mmol/L < 5.20 179 mg/dL < 200
HDL Cholesterol 1.30 mmol/L > 1.03 50 mg/dL > 40
Non-HDL Cholesterol 3.35 mmol/L < 3.36 130 mg/dL < 130
Triglycerides 0.77 mmol/L < 1.70 68 mg/dL < 150
LDL Cholesterol ▲ 3.00 mmol/L < 2.58 116 mg/dL < 100
VLDL Cholesterol 0.35 mmol/L < 0.80 13 mg/dL < 31
Total Cholesterol/HDL 3.58 ratio < 5.00 3.6 ratio < 5.0

Diabetic Studies
Glucose (Fasting) ▲ 6.13 mmol/L 3.89 - 5.83 110.45 mg/dL 70.09 - 105.04

RESULT FLAGS ▼ Low ▼▼Critically Low ▲ High ▲▲Critically High

THIS IS A COMPUTER GENERATED REPORT. LAB ID: L2402160020 RELEASED ON: 16-Feb-2024 11:00 Page 1 of 2
~~
! 2 1 7 6 3 6 6 _ MAXPCCAL _ REGIL ME-E VEL YN-G_ 0 1 1 5 1 9 6 9 _ L 2 4 0 2 1 6 0 0 2 0 _ EMEDSAPCC-3 8 0 0 3 5 2 2
- 0148531
- 168011108506034

PATIENT NAME
REGILME, EVELYN G.
MAXICARE PCC - ALABANG

DOB AGE SEX SAMPLE RECEIVE DATE/TIME YOUR REF REFERRING DOCTOR
JAN 15 1969 55Y F FEB 16 2024 07:33 EMEDSAPCC-3800352-2014853 NOT PROVIDED
-1168011108506034

ANALYTE RESULT SI UNIT REF RANGE RESULT CONV UNIT REF RANGE

Diabetic Studies
HbA1c (IFCC) ▲ 47.0 mmol/mol 20.2 - 37.7 47.0 mmol/mol 20.2 - 37.7

Non-diabetic: 20.2 - 37.7 mmol/mol

Pre-diabetes: 38.8 - 46.4 mmol/mol
Diabetic: >=47.5 mmol/mol

HbA1c (NGSP) ▲ 6.40 % 4.00 - 5.60 6.40 % 4.00 - 5.60

Non-diabetic: 4.0 - 5.6 %

Pre-diabetes: 5.7 - 6.4 %
Diabetic: >=6.5 %

Estimated Average Glucose (eAG) 7.6 mmol/L 137 mg/dL

Method: Ion Exchange High Performance Liquid Chromatography (HPLC)

Important Notice
This lab report is intended to be interpreted by a qualified medical doctor in conjunction with clinical evaluation and other diagnostic procedures.

Validated by
Scientist Earl Jude P. Ambray RMT (PRC License# 0069371)
Pathologist Paulo Giovanni L. Mendoza M.D. (PRC License# 0098131)

Sample Collection Date/Time

EDTA WB 16-Feb-2024 07:33
FluorideF 16-Feb-2024 07:33
Serum 16-Feb-2024 07:33

Test Status
Released Sodium, Creatinine (with eGFR), Potassium, Urea / BUN, Uric Acid (BUA), ALT (SGPT), Lipid Profile, Fasting, Glucose
(Fasting), HbA1c

RESULT FLAGS ▼ Low ▼▼Critically Low ▲ High ▲▲Critically High

THIS IS A COMPUTER GENERATED REPORT. LAB ID: L2402160020 RELEASED ON: 16-Feb-2024 11:00 Page 2 of 2